Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2016-01-31
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EMERGEncy Versus Delayed Coronary Angiogram in Survivors of Out-of-hospital Cardiac Arrest
NCT02876458
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
NCT04043091
Impact of Ischemic Post-conditioning
NCT04068116
Direct or Subacute Coronary Angiography in Out-of-hospital Cardiac Arrest
NCT02309151
Cangrelor in Patients With Acute Myocardial Infarction Undergoing PCI After CPR, Ventilated or Cardiogenic Shock
NCT04611607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The randomization will be in a 1:1 ratio to urgent or deferred coronary angiography.
The main objective of the study is to compare the effectiveness of an urgent coronary angiography and angioplasty if necessary versus a deferred coronary angiography in survivors from OHCA who after recovery of spontaneous circulation do not fulfill criteria for ST-elevation myocardial infarction.
The primary efficacy endpoint is a composite of in-hospital survival and six-month survival free of severe dependence, which will be evaluated by using the Cerebral Performance Category (CPC) Scale, being good prognosis represented by the categories 1 and 2.The safety endpoint will be a composite of MACE (Major Adverse Cardiac Events) including: death, reinfarction, bleeding or ventricular arrhythmias.
A total of 166 patients will be included. The estimated duration will be 42 months, with a target follow-up of 6 months. Periods will be divided as follows:
* Inclusion Period (selection of the population and data collection): 36 months.
* Monitoring, data analysis, statistical and clinical report: 6 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Urgent Coronary Angiography
Urgent Coronary Angiography: as soon as possible, when the patient is randomized.
Urgent Coronary Angiography
Diagnostic test for the evaluation of the coronary vasculature.
Deferred coronariography
Deferred coronary angiography: after extubation if the patient has a good neurologic prognosis.
Deferred Coronary Angiography
Diagnostic test for the evaluation of the coronary vasculature.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urgent Coronary Angiography
Diagnostic test for the evaluation of the coronary vasculature.
Deferred Coronary Angiography
Diagnostic test for the evaluation of the coronary vasculature.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Show a non-diagnostic electrocardiogram after ROSC (neither ST segment elevation nor left bundle branch block).
* Prior rule out of an obvious non-cardiac cause of the cardiac arrest (head CT scan and transthoracic echocardiogram).
Exclusion Criteria
* Pregnant women or women of childbearing age unless they have a negative pregnancy test.
* Time to return of spontaneous circulation longer than 60 minutes.
* Non-cardiac etiology of the comatose state: drug overdose, head injury or stroke.
* Acute myocardial infarction with ST segment elevation or left bundle branch block, because in those patients emergent angiography is mandatory.
* Hemodynamic instability (refractory cardiogenic shock despite vasoactive drugs or refractory arrhythmias), because in those patients an emergent angiography is mandatory.
* Known coagulopathy or bleeding.
* Refusal to participate in the study by the next of kin.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Clínico Universitario de Valladolid
OTHER
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER
Hospital Vall d'Hebron
OTHER
Hospital Arnau de Vilanova
OTHER
Hospital Universitari de Bellvitge
OTHER
Hospital General Universitario Gregorio Marañon
OTHER
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
OTHER
Hospital Universitario Ramon y Cajal
OTHER
Hospital Clinic of Barcelona
OTHER
Hospital Universitario Virgen Macarena
OTHER
Hospital Universitario de Canarias
OTHER
Germans Trias i Pujol Hospital
OTHER
Complejo Hospitalario Universitario de Santiago
OTHER
Hospital Universitario Principe de Asturias
OTHER
Hospital Universitari Joan XXIII de Tarragona.
OTHER
Hospital de Leon
OTHER_GOV
Hospital San Carlos, Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana Viana Tejedor
MD. PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana Viana Tejedor, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Clinico San Carlos
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clínico San Carlos
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Camuglia AC, Randhawa VK, Lavi S, Walters DL. Cardiac catheterization is associated with superior outcomes for survivors of out of hospital cardiac arrest: review and meta-analysis. Resuscitation. 2014 Nov;85(11):1533-40. doi: 10.1016/j.resuscitation.2014.08.025. Epub 2014 Sep 4.
Morrison LJ, Neumar RW, Zimmerman JL, Link MS, Newby LK, McMullan PW Jr, Hoek TV, Halverson CC, Doering L, Peberdy MA, Edelson DP; American Heart Association Emergency Cardiovascular Care Committee, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on P. Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: a consensus statement from the American Heart Association. Circulation. 2013 Apr 9;127(14):1538-63. doi: 10.1161/CIR.0b013e31828b2770. Epub 2013 Mar 11. No abstract available.
Viana-Tejedor A, Andrea-Riba R, Scardino C, Ariza-Sole A, Baneras J, Garcia-Garcia C, Jimenez Mena M, Vila M, Martinez-Selles M, Pastor G, Garcia Acuna JM, Loma-Osorio P, Garcia Rubira JC, Jorge Perez P, Pastor P, Ferrera C, Noriega FJ, Perez Macias N, Fernandez-Ortiz A, Perez-Villacastin J; COUPE Investigators. Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial. Rev Esp Cardiol (Engl Ed). 2023 Feb;76(2):94-102. doi: 10.1016/j.rec.2022.05.013. Epub 2022 Jun 22. English, Spanish.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COUPE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.